Expansion of human mesenchymal stromal cells from fresh bone marrow in a 3D scaffold-based system under direct perfusion

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Papadimitropoulos, Adam ^a   Piccinini, Elia ^a   Brachat, Sophie ^b   Braccini, Alessandra ^a   Wendt, David ^a   Barbero, Andrea ^a   Jacobi, Carsten ^b   Martin, Ivan ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOMATION; BIOREACTOR; BONE MARROW; CELL THERAPY; CLONOGENESIS; CULTURE MEDIUM; CYTOFLUOROMETRY; FLOW CYTOMETRY; GENE CLUSTER; HUMAN; HUMAN CELL; MESENCHYMAL STROMA CELL; MICROARRAY ANALYSIS; MOLECULAR MEDICINE; MONOLAYER CULTURE; MULTINUCLEAR CELL; TRANSCRIPTOMICS; UPREGULATION; CELL PROLIFERATION; CELL SEPARATION; CULTURE TECHNIQUE; CYTOLOGY; DEVICES; DNA MICROARRAY; PERFUSION; PHENOTYPE; PROCEDURES;

BIOREACTORS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SEPARATION; HUMANS; MESENCHYMAL STROMAL CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERFUSION; PHENOTYPE;

EID: 84904264969     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102359     Document Type: Article

References (60)

1. Uccelli A, Moretta L, Pistoia V (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8: 726-736. 10.1038/nri2395 [doi].
2. Almeida-Porada G, Porada CD, Tran N, Zanjani ED (2000) Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation. Blood 95: 3620-3627. (Pubitemid 30428501)
3. Pereira RF, Halford KW, O'Hara MD, Leeper DB, Sokolov BP, et al. (1995) Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci U S A 92: 4857-4861.
4. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, et al. (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705. 10.1038/35070587 [doi];35070587 [pii].
5. Banfi A, Muraglia A, Dozin B, Mastrogiacomo M, Cancedda R, et al. (2000) Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp Hematol 28: 707-715. S0301-472X(00)00160-0 [pii].
6. Banfi A, Bianchi G, Notaro R, Luzzatto L, Cancedda R, et al. (2002) Replicative aging and gene expression in long-term cultures of human bone marrow stromal cells. Tissue Eng 8: 901-910. 10.1089/107632702320934001 [doi]. (Pubitemid 35397236)
7. Augello A, Kurth TB, De BC (2010) Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches. Eur Cell Mater 20: 121-133. vol020a11 [pii].
8. da Silva ML, Caplan AI, Nardi NB (2008) In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26: 2287-2299. 2007-1122 [pii];10.1634/stemcells.2007-1122 [doi].
9. Lai Y, Sun Y, Skinner CM, Son EL, Lu Z, et al. (2010) Reconstitution of marrow-derived extracellular matrix ex vivo: a robust culture system for expanding large-scale highly functional human mesenchymal stem cells. Stem Cells Dev 19: 1095-1107. 10.1089/scd.2009.0217 [doi].
10. Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, et al. (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466: 829-834. nature09262 [pii];10.1038/nature09262 [doi].
11. Scadden DT (2006) The stem-cell niche as an entity of action. Nature 441: 1075-1079. nature04957 [pii];10.1038/nature04957 [doi].
12. Bara JJ, Richards RG, Alini M, Stoddart MJ (2014) Bone marrow-derived mesenchymal stem cells change phenotype following in vitro culture: Implications for basic research and the clinic. Stem Cells. 10.1002/stem.1649 [doi].
13. Chen X, Xu H, Wan C, McCaigue M, Li G (2006) Bioreactor expansion of human adult bone marrow-derived mesenchymal stem cells. Stem Cells 24: 2052-2059. 2005-0591 [pii];10.1634/stemcells.2005-0591 [doi].
14. Frith JE, Thomson B, Genever PG (2010) Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. Tissue Eng Part C Methods 16: 735-749. 10.1089/ten.TEC.2009.0432 [doi].
15. Eibes G, dos SF, Andrade PZ, Boura JS, Abecasis MM, et al. (2010) Maximizing the ex vivo expansion of human mesenchymal stem cells using a microcarrier-based stirred culture system. J Biotechnol 146: 194-197. S0168-1656(10)00101-X [pii];10.1016/j.jbiotec.2010.02.015 [doi].
16. Yang Y, Rossi FM, Putnins EE (2007) Ex vivo expansion of rat bone marrow mesenchymal stromal cells on microcarrier beads in spin culture. Biomaterials 28: 3110-3120. S0142-9612(07)00237-2 [pii];10.1016/j.biomaterials.2007.03.015 [doi].
17. Frauenschuh S, Reichmann E, Ibold Y, Goetz PM, Sittinger M, et al. (2007) A microcarrier-based cultivation system for expansion of primary mesenchymal stem cells. Biotechnol Prog 23: 187-193. 10.1021/bp060155w [doi]. (Pubitemid 46293503)
18. Diederichs S, Roker S, Marten D, Peterbauer A, Scheper T, et al. (2009) Dynamic cultivation of human mesenchymal stem cells in a rotating bed bioreactor system based on the Z RP platform. Biotechnol Prog 25: 1762-1771. 10.1002/btpr.258 [doi].
19. Reichardt A, Polchow B, Shakibaei M, Henrich W, Hetzer R, et al. (2013) Large scale expansion of human umbilical cord cells in a rotating bed system bioreactor for cardiovascular tissue engineering applications. Open Biomed Eng J 7: 50-61. 10.2174/1874120701307010050 [doi];TOBEJ-7-50 [pii].
20. Di Maggio N, Mehrkens A, Papadimitropoulos A, Schaeren S, Heberer M, et al. (2012) Fibroblast growth factor-2 maintains a niche-dependent population of self-renewing highly potent non-adherent mesenchymal progenitors through FGFR2c. Stem Cells 30: 1455-1464. 10.1002/stem.1106 [doi].
21. Eipers PG, Kale S, Taichman RS, Pipia GG, Swords NA, et al. (2000) Bone marrow accessory cells regulate human bone precursor cell development. Exp Hematol 28: 815-825. S0301472X00001831 [pii].
22. Baksh D, Davies JE, Zandstra PW (2003) Adult human bone marrow-derived mesenchymal progenitor cells are capable of adhesion-independent survival and expansion. Exp Hematol 31: 723-732. S0301472X03001061 [pii].
23. Baksh D, Davies JE, Zandstra PW (2005) Soluble factor cross-talk between human bone marrow-derived hematopoietic and mesenchymal cells enhances in vitro CFU-F and CFU-O growth and reveals heterogeneity in the mesenchymal progenitor cell compartment. Blood 106: 3012-3019. 2005-01-0433 [pii];10.1182/blood-2005- 01-0433 [doi].
24. Braccini A, Wendt D, Jaquiery C, Jakob M, Heberer M, et al. (2005) Three-dimensional perfusion culture of human bone marrow cells and generation of osteoinductive grafts. Stem Cells 23: 1066-1072. 2005-0002 [pii];10.1634/ stemcells.2005-0002 [doi].
25. Di Maggio N, Piccinini E, Jaworski M, Trumpp A, Wendt DJ, et al. (2011) Toward modeling the bone marrow niche using scaffold-based 3D culture systems. Biomaterials 32: 321-329. S0142-9612(10)01238-X [pii];10.1016/j.biomaterials. 2010.09.041 [doi].
26. Wendt D, Marsano A, Jakob M, Heberer M, Martin I (2003) Oscillating perfusion of cell suspensions through three-dimensional scaffolds enhances cell seeding efficiency and uniformity. Biotechnol Bioeng 84: 205-214. 10.1002/bit.10759 [doi]. (Pubitemid 37176332)
27. Merico D, Isserlin R, Stueker O, Emili A, Bader GD (2010) Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PLoS One 5: e13984. 10.1371/journal.pone.0013984 [doi].
28. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13: 2498-2504. 10.1101/gr.1239303 [doi];13/11/2498 [pii].
29. Mauney JR, Jaquiery C, VollochV,HebererM, Martin I, et al. (2005) In vitro and in vivo evaluation of differentially demineralized cancellous bone scaffolds combined with human bone marrow stromal cells for tissue engineering. Biomaterials 26: 3173-3185. S0142-9612(04)00769-0 [pii];10.1016/j.biomaterials. 2004.08.020 [doi].
30. Barbero A, Ploegert S, Heberer M, Martin I (2003) Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Arthritis Rheum 48: 1315-1325. 10.1002/art.10950 [doi]. (Pubitemid 36554530)
31. Bocelli-Tyndall C, Bracci L, Schaeren S, Feder-Mengus C, Barbero A, et al. (2009) Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15. Ann Rheum Dis 68: 1352-1359. ard.2008.094003 [pii];10.1136/ard.2008.094003 [doi].
32. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147. (Pubitemid 29282067)
33. Harichandan A, Buhring HJ (2011) Prospective isolation of human MSC. Best Pract Res Clin Haematol 24: 25-36. S1521-6926(11)00002-8 [pii];10.1016/j.beha. 2011.01.001 [doi].
34. Russell KC, Phinney DG, Lacey MR, Barrilleaux BL, Meyertholen KE, et al. (2010) In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells 28: 788-798. 10.1002/stem.312 [doi].
35. Sorrentino A, Ferracin M, Castelli G, Biffoni M, Tomaselli G, et al. (2008) Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Exp Hematol 36: 1035-1046. S0301-472X(08)00118-5 [pii];10.1016/j.exphem. 2008.03.004 [doi].
36. Anjos-Afonso F, Bonnet D (2007) Nonhematopoietic/endothelial SSEA-1+ cells define the most primitive progenitors in the adult murine bone marrow mesenchymal compartment. Blood 109: 1298-1306. blood-2006-06-030551 [pii];10.1182/blood-2006-06-030551 [doi].
37. Sacchetti B, Funari A, Michienzi S, Di CS, Piersanti S, et al. (2007) Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131: 324-336. S0092-8674(07)01087-2 [pii];10.1016/j.cell.2007.08.025 [doi].
38. Raychaudhuri S, Stuart JM, Altman RB (2000) Principal components analysis to summarize microarray experiments: application to sporulation time series. Pac Symp Biocomput 455-466.
39. Muller FJ, Laurent LC, Kostka D, Ulitsky I, Williams R, et al. (2008) Regulatory networks define phenotypic classes of human stem cell lines. Nature 455: 401-405. nature07213 [pii];10.1038/nature07213 [doi].
40. Bianco P, Robey PG, Simmons PJ (2008) Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2: 313-319. S1934-5909(08)00114-8 [pii];10.1016/j.stem.2008.03.002 [doi].
41. Dominici M, Le BK, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317. Q2183N8UT042W62H [pii];10.1080/14653240600855905 [doi].
42. Bocelli-Tyndall C, Zajac P, Di Maggio N, Trella E, Benvenuto F, et al. (2010) Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells. Arthritis Rheum 62: 3815-3825. 10.1002/art.27736 [doi].
43. Tarte K, Gaillard J, Lataillade JJ, Fouillard L, Becker M, et al. (2010) Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 115: 1549-1553. blood-2009-05-219907 [pii];10.1182/blood-2009-05-219907 [doi].
44. Muraglia A, Cancedda R, Quarto R (2000) Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113 (Pt 7): 1161-1166. (Pubitemid 30229533)
45. Zhu J, Shimizu E, Zhang X, Partridge NC, Qin L (2011) EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix. J Cell Biochem 112: 1749-1760. 10.1002/jcb.23094 [doi].
46. Pevsner-Fischer M, Morad V, Cohen-Sfady M, Rousso-Noori L, Zanin-Zhorov A, et al. (2007) Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 109: 1422-1432. blood-2006-06-028704 [pii];10.1182/blood- 2006-06-028704 [doi].
47. Fehrer C, Brunauer R, Laschober G, Unterluggauer H, Reitinger S, et al. (2007) Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell 6: 745-757. ACE336 [pii];10.1111/j.1474-9726.2007.00336.x [doi].
48. Estrada JC, Albo C, Benguria A, Dopazo A, Lopez-Romero P, et al. (2012) Culture of human mesenchymal stem cells at low oxygen tension improves growth and genetic stability by activating glycolysis. Cell Death Differ 19: 743-755. cdd2011172 [pii];10.1038/cdd.2011.172 [doi].
49. Pedersen JA, Swartz MA (2005) Mechanobiology in the third dimension. Ann Biomed Eng 33: 1469-1490. 10.1007/s10439-005-8159-4 [doi]. (Pubitemid 41801636)
50. Trappmann B, Gautrot JE, Connelly JT, Strange DG, Li Y, et al. (2012) Extracellular-matrix tethering regulates stem-cell fate. Nat Mater 11: 642-649. nmat3339 [pii];10.1038/nmat3339 [doi].
51. Li B, Moshfegh C, Lin Z, Albuschies J, Vogel V (2013) Mesenchymal stem cells exploit extracellular matrix as mechanotransducer. Sci Rep 3: 2425. srep02425 [pii];10.1038/srep02425 [doi].
52. Cukierman E, Pankov R, Yamada KM (2002) Cell interactions with three-dimensional matrices. Curr Opin Cell Biol 14: 633-639. S0955067402003642 [pii].
53. Zhang ZL, Tong J, Lu RN, Scutt AM, Goltzman D, et al. (2009) Therapeutic potential of non-adherent BM-derived mesenchymal stem cells in tissue regeneration. Bone Marrow Transplant 43: 69-81. bmt2008260 [pii];10.1038/bmt. 2008.260 [doi].
54. Chen XD, Dusevich V, Feng JQ, Manolagas SC, Jilka RL (2007) Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts. J Bone Miner Res 22: 1943-1956. 10.1359/jbmr.070725 [doi]. (Pubitemid 351229311)
55. Prewitz MC, Seib FP, von BM, Friedrichs J, Stissel A, et al. (2013) Tightly anchored tissue-mimetic matrices as instructive stem cell microenvironments. Nat Methods 10: 788-794. nmeth.2523 [pii];10.1038/nmeth.2523 [doi].
56. Hillsley MV, Frangos JA (1994) Bone tissue engineering: the role of interstitial fluid flow. Biotechnol Bioeng 43: 573-581. 10.1002/bit.260430706 [doi]. (Pubitemid 24090704)
57. Owan I, Burr DB, Turner CH, Qiu J, Tu Y, et al. (1997) Mechanotransduction in bone: osteoblasts are more responsive to fluid forces than mechanical strain. Am J Physiol 273: C810-C815.
58. You J, Yellowley CE, Donahue HJ, Zhang Y, Chen Q, et al. (2000) Substrate deformation levels associated with routine physical activity are less stimulatory to bone cells relative to loading-induced oscillatory fluid flow. J Biomech Eng 122: 387-393.
59. Scaglione S, Braccini A, Wendt D, Jaquiery C, Beltrame F, et al. (2006) Engineering of osteoinductive grafts by isolation and expansion of ovine bone marrow stromal cells directly on 3D ceramic scaffolds. Biotechnol Bioeng 93: 181-187. 10.1002/bit.20677 [doi]. (Pubitemid 43117070)
60. Martin I, Simmons PJ, Williams DF (2014) Manufacturing Challenges in Regenerative Medicine. Sci. Transl. Med. 6, 232fs16.